Curcuma oil ameliorates hyperlipidaemia and associated deleterious effects in golden Syrian hamsters

British Journal of Nutrition

Volumn 110, Issue 3, 2013, Pages 437-446

  Singh, Vishal ^a   Jain, Manish ^a   Misra, Ankita ^a   Khanna, Vivek ^a   Rana, Minakshi ^a   Prakash, Prem ^a   Malasoni, Richa ^a   Dwivedi, Anil Kumar ^a   Dikshit, Madhu ^a   Barthwal, Manoj Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Curcuma oil; Hamsters; Hyperlipidaemia; Liver X receptor ; PPAR

Indexed keywords

ABC TRANSPORTER A1; CD68 ANTIGEN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CURCUMA EXTRACT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ABCA1 GENE; ABCG5 GENE; ABCG8 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD68 GENE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; CURCUMA LONGA; CYP7A1 GENE; DRUG MECHANISM; ENOS GENE; GENE; GENE EXPRESSION; HMGCR GENE; HYPERLIPIDEMIA; LIVER FUNCTION; LPL GENE; LXRALPHA GENE; NONHUMAN; NPC1L1 GENE; OXIDATIVE STRESS; PPARALPHA GENE; SREBP 2 GENE; THROMBOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTA; CHOLESTEROL, DIETARY; CRICETINAE; CURCUMA; HYPERCHOLESTEROLEMIA; JEJUNUM; LIVER; MALE; MESOCRICETUS; NITRIC OXIDE SYNTHASE TYPE III; OILS, VOLATILE; ORPHAN NUCLEAR RECEPTORS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT PREPARATIONS; PLATELET ACTIVATION; PPAR ALPHA; RNA, MESSENGER; TRIGLYCERIDES; VASCULAR DISEASES;

EID: 84880818337     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512005363     Document Type: Article

References (52)

1. Singh S (2007) From exotic spice to modern drug? Cell 130, 765-768.
2. Ray MPR, Singh S, Khanna NM. (2006) Herbal medicaments for the treatment of neurocerebrovascular disorders. http://www.freepatentsonline.com/6991814.html
3. Jain V, Prasad V, Pal R, et al. (2007) Standardization and stability studies of neuroprotective lipid soluble fraction obtained from Curcuma longa. J Pharm Biomed Anal 44, 1079-1086.
4. Prakash P, Misra A, Surin WR, et al. (2011) Anti-platelet effects of curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 127, 111-118.
5. Prakash P, Khanna V, Singh V, et al. (2011) Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats. Cardiovasc Drugs Ther 25, 285-297.
6. Dohare P, Garg P, Sharma U, et al. (2008) Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model. BMC Complement Altern Med 8, 55.
7. Dohare P, Varma S & Ray M (2008) Curcuma oil modulates the nitric oxide system response to cerebral ischemia/reperfusion injury. Nitric Oxide 19, 1-11.
8. Rathore P, Dohare P, Varma S, et al. (2008) Curcuma oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem Res 33, 1672-1682.
9. Jayaprakasha GK, Jena BS, Negi PS, et al. (2002) Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from curcumin production. Z Naturforsch C 57, 828-835.
10. Sandur SK, Pandey MK, Sung B, et al. (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28, 1765-1773.
11. Lee Y (2009) Activation of apoptotic protein in U937 cells by a component of turmeric oil. BMB Rep 42, 96-100.
12. Liju VB, Jeena K & Kuttan R (2011) An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa L. Indian J Pharmacol 43, 526-531.
13. Li AC & Glass CK (2004) PPAR-and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res 45, 2161-2173.
14. Valasek MA, Clarke SL & Repa JJ (2007) Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. J Lipid Res 48, 2725-2735.
15. Rakhshandehroo M, Knoch B, Muller M, et al. (2010) Peroxisome proliferator-activated receptor alpha target genes. PPAR Res 2010, article ID 612089.
16. Briand F, Treguier M, Andre A, et al. (2010) Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. J Lipid Res 51, 763-770.
17. Singh V, Tiwari RL, Dikshit M, et al. (2009) Models to study atherosclerosis: a mechanistic insight. Curr Vasc Pharmacol 7, 75-109.
18. Zhang Z, Wang H, Jiao R, et al. (2009) Choosing hamsters but not rats as a model for studying plasma cholesterollowering activity of functional foods. Mol Nutr Food Res 53, 921-930.
19. Singh V, Jain M, Prakash P, et al. (2011) A time course study on prothrombotic parameters and their modulation by antiplatelet drugs in hyperlipidemic hamsters. J Physiol Biochem 67, 205-216.
20. Jain M, Barthwal MK, Haq W, et al. (2012) Synthesis and pharmacological evaluation of novel arginine analogs as potential inhibitors of acetylcholine-induced relaxation in rat thoracic aortic rings. Chem Biol Drug Des 79, 459-469.
21. Khanna V, Jain M, Barthwal MK, et al. (2011) Vasomodulatory effect of novel peroxovanadate compounds on rat aorta: role of rho kinase and nitric oxide/cGMP pathway. Pharmacol Res 64, 274-282.
22. Hara A & Radin NS (1978) Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 90, 420-426.
23. Poirier J, Cockell KA, Scoggan KA, et al. (2012) High-dose supplemental selenite to male Syrian hamsters fed hypercholesterolaemic diets alters Ldlr, Abcg8 and Npc1l1 mRNA expression and lowers plasma cholesterol concentrations. Br J Nutr 108, 257-266.
24. Tiwari RL, Singh V, Singh A, et al. (2011) IL-1R-associated kinase-1 mediates protein kinase Cdelta-induced IL-1beta production in monocytes. J Immunol 187, 2632-2645.
25. Lee HS (2006) Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresour Technol 97, 1372-1376.
26. Reagan-Shaw S, Nihal M & Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22, 659-661.
27. Hastak K, Lubri N, Jakhi SD, et al. (1997) Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 116, 265-269.
28. Joshi J, Ghaisas S, Vaidya A, et al. (2003) Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Assoc Physicians India 51, 1055-1060.
29. Ng TP, Chiam PC, Lee T, et al. (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164, 898-906.
30. Hutchins-Wolfbrandt A & Mistry AM (2011) Dietary turmeric potentially reduces the risk of cancer. Asian Pac J Cancer Prev 12, 3169-3173.
31. Guo Q, Wang PR, Milot DP, et al. (2001) Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim Biophys Acta 1533, 220-232.
32. Mukherjee R, Locke KT, Miao B, et al. (2008) Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist. J Pharmacol Exp Ther 327, 716-726.
33. Srivastava RA (2011) Evaluation of anti-atherosclerotic activities of PPAR-alpha, PPAR-gamma, and LXR agonists in hyperlipidemic atherosclerosis- susceptible F(1)B hamsters. Atherosclerosis 214, 86-93.
34. Davis HR Jr, Compton DS, Hoos L, et al. (2001) Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler Thromb Vasc Biol 21, 2032-2038.
35. Valasek MA, Repa JJ, Quan G, et al. (2008) Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters. Am J Physiol Gastrointest Liver Physiol 295, G813-G822.
36. Goya K, Sumitani S, Xu X, et al. (2004) Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 24, 658-663.
37. Lecker JL, Matthan NR, Billheimer JT, et al. (2010) Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1B hamster. Metabolism 59, 1491-1501.
38. Kalaany NY & Mangelsdorf DJ (2006) LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68, 159-191.
39. Davis HR Jr, Basso F, Hoos LM, et al. (2008) Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1). Atheroscler Suppl 9, 77-81.
40. Staels B, Dallongeville J, Auwerx J, et al. (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088-2093.
41. Konig B, Koch A, Spielmann J, et al. (2007) Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem Pharmacol 73, 574-585.
42. Van Rooyen DM & Farrell GC (2011) SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH. J Gastroenterol Hepatol 26, 789-792.
43. Yu L, Li-Hawkins J, Hammer RE, et al. (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110, 671-680.
44. Hossain MA, Tsujita M, Gonzalez FJ, et al. (2008) Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes. J Cardiovasc Pharmacol 51, 258-266.
45. Duval C, Touche V, Tailleux A, et al. (2006) Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun 340, 1259-1263.
46. Forcheron F, Cachefo A, Thevenon S, et al. (2002) Mechanisms of the triglyceride-and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes 51, 3486-3491.
47. Beaven SW & Tontonoz P (2006) Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 57, 313-329.
48. Srivastava RA & He S (2010) Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster. Mol Cell Biochem 345, 197-206.
49. Saurav A, Kaushik M & Mohiuddin SM (2012) Fenofibric acid for hyperlipidemia. Expert Opin Pharmacother 13, 717-722.
50. Li G, Liu X, Zhu H, et al. (2009) Insulin resistance in insulinresistant and diabetic hamsters (Mesocricetus auratus) is associated with abnormal hepatic expression of genes involved in lipid and glucose metabolism. Comp Med 59, 449-458.
51. Marinho M, Oliveira-Junior IS, Monteiro CM, et al. (2009) Pulmonary disease in hamsters infected with Leptospira interrogans: histopathologic findings and cytokine mRNA expressions. Am J Trop Med Hyg 80, 832-836.
52. Kim H, Bartley GE, Rimando AM, et al. (2010) Hepatic gene expression related to lower plasma cholesterol in hamsters fed high-fat diets supplemented with blueberry peels and peel extract. J Agric Food Chem 58, 3984-3991.